Rifadin Iv Injection, Powder, Lyophilized, For Solution
Product Images NDC 0068-0597

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rifadin Iv (NDC 0068-0597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rifadin 01)

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Principal Display Panel (150 mg Capsule Bottle Label)
Rifadin IV is an injection medicine used for IV infusion only. It contains rifampin and other substances for adjusting the pH level. The solution is reconstituted with sterilized water and should be used within 30 hours. The package insert contains dosage and stability data. It should be stored at controlled room temperature and protected from excessive heat and light. This product is distributed by Sanofi-Aventis, a pharmaceutical company based in Bridgewater, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.